Rare diseases
Investigational molecules
Locations
5850 Canoga Avenue Floor 4, 91367-6554, United States
Angitia Inc. Ltd. focuses on postmenopausal osteoporosis and low bone mass, with research centered on improving bone mineral density in women affected by skeletal fragility.
The sponsor’s clinical activity is directed toward therapies relevant to lumbar spine bone loss and the broader management of age-related weakening of the skeleton.
Angitia Inc. Ltd. runs clinical trials in conditions such as Osteogenesis imperfecta, Osteoporosis postmenopausal, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Denmark
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
